Rocket Pharmaceuticals, Inc. (RCKT) Social Stream
ROCKET PHARMACEUTICALS INC (RCKT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RCKT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-14 | 10 | $75 | $56 | $66.75 | $29.43 | 126.81% |
| 2021-12-15 | 10 | $75 | $60 | $66.142 | $29.43 | 124.74% |
| 2022-01-28 | 9 | $75 | $60 | $66.142 | $29.43 | 124.74% |
| 2022-02-01 | 9 | $75 | $60 | $65.428 | $29.43 | 122.32% |
| 2022-02-24 | 8 | $69 | $60 | $63.833 | $29.43 | 116.9% |
| 2022-02-25 | 7 | $67 | $60 | $63 | $29.43 | 114.07% |
| 2022-04-25 | 7 | $67 | $57 | $62.166 | $29.43 | 111.23% |
| 2022-05-06 | 8 | $67 | $57 | $62.166 | $29.43 | 111.23% |
| 2022-05-09 | 9 | $75 | $30 | $57.857 | $29.43 | 96.59% |
| 2022-05-19 | 9 | $67 | $30 | $56.714 | $29.43 | 92.71% |
| 2022-05-21 | 9 | $67 | $30 | $57.285 | $29.43 | 94.65% |
| 2022-06-08 | 9 | $67 | $30 | $56 | $29.43 | 90.28% |
| 2022-08-09 | 10 | $67 | $22 | $50.125 | $29.43 | 70.32% |
| 2022-09-17 | 10 | $67 | $24 | $52.125 | $29.43 | 77.12% |
| 2022-09-20 | 10 | $67 | $24 | $52 | $29.43 | 76.69% |
| 2022-09-27 | 11 | $67 | $24 | $53.333 | $29.43 | 81.22% |
| 2022-09-30 | 12 | $75 | $24 | $55.5 | $29.43 | 88.58% |
| 2022-10-03 | 12 | $75 | $34 | $56.5 | $29.43 | 91.98% |
| 2022-10-06 | 12 | $75 | $34 | $56.8 | $29.43 | 93% |
| 2022-10-12 | 11 | $75 | $34 | $56.3 | $29.43 | 91.3% |
| 2022-10-24 | 11 | $75 | $34 | $55.9 | $29.43 | 89.94% |
| 2022-11-01 | 12 | $75 | $34 | $54 | $29.43 | 83.49% |
| 2022-11-04 | 12 | $75 | $34 | $53.909 | $29.43 | 83.18% |
| 2022-11-07 | 12 | $75 | $33 | $53.818 | $29.43 | 82.87% |
| 2022-11-08 | 13 | $75 | $33 | $53.583 | $29.43 | 82.07% |
| 2022-12-13 | 13 | $75 | $33 | $53.416 | $29.43 | 81.5% |
| 2022-12-22 | 13 | $75 | $33 | $52.833 | $29.43 | 79.52% |
| 2023-01-10 | 13 | $75 | $33 | $53.166 | $29.43 | 80.65% |
| 2023-01-25 | 13 | $75 | $33 | $53.083 | $29.43 | 80.37% |
| 2023-02-08 | 14 | $75 | $33 | $52.461 | $29.43 | 78.26% |
| 2023-02-28 | 14 | $75 | $33 | $52.23 | $29.43 | 77.47% |
| 2023-03-01 | 14 | $75 | $33 | $52 | $29.43 | 76.69% |
| 2023-04-19 | 14 | $75 | $33 | $52.076 | $29.43 | 76.95% |
| 2023-05-08 | 14 | $75 | $35 | $52.23 | $29.43 | 77.47% |
| 2023-06-28 | 14 | $75 | $35 | $52.076 | $29.43 | 76.95% |
| 2023-08-11 | 12 | $75 | $39 | $54.181 | $29.43 | 84.1% |
| 2023-08-14 | 12 | $75 | $39 | $54 | $29.43 | 83.49% |
| 2023-09-13 | 12 | $75 | $39 | $53.363 | $29.43 | 81.32% |
| 2023-09-14 | 12 | $75 | $39 | $53.09 | $29.43 | 80.39% |
| 2023-10-02 | 11 | $65 | $39 | $50.9 | $29.43 | 72.95% |
| 2023-11-07 | 12 | $65 | $39 | $52.272 | $29.43 | 77.61% |
| 2023-11-08 | 12 | $65 | $39 | $52.545 | $29.43 | 78.54% |
| 2023-11-12 | 12 | $65 | $37 | $52.09 | $29.43 | 77% |
| 2023-12-26 | 13 | $65 | $37 | $52.091 | $29.43 | 77% |
The Trend in the Analyst Price Target
RCKT's average price target has moved up $16.89 over the prior 44 months.
Over the past 50 weeks, RCKT's average upside potential has been 160.49%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-08 | 14 | 75 | 35 | 52.076 | 21.36 | 143.8% |
| 2023-06-28 | 13 | 75 | 35 | 53.500 | 20.66 | 158.95% |
| 2023-10-02 | 11 | 65 | 39 | 50.900 | 19.45 | 161.7% |
| 2023-11-07 | 12 | 65 | 39 | 52.272 | 20.47 | 155.36% |
| 2023-11-12 | 12 | 65 | 37 | 52.090 | 18.55 | 180.81% |
RCKT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.08 | 12 | 1 | 0 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
RCKT's average broker recommendation rating improved by 0.03 over the prior 23 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RCKT as an investment opportunity.
- RCKT has a lower variance in analysts' estimates than -3402.12% of all US stocks.
- In terms of how ROCKET PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 4117.5% of that group.
- RCKT has a higher number of analysts covering the stock than 4114.5% of stocks in the mid market cap category.
- In the context of Pharmaceutical Products stocks, ROCKET PHARMACEUTICALS INC's average analyst price target is higher than 3832.14% of them.
In the Pharmaceutical Products industry, CERE, NUVB, and PRLD are the three stocks most similar to ROCKET PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is RCKT a Buy, Hold or Sell? See the POWR Ratings now!